Clinical Trial: A Double Blind Crossover Trial of Levetiracetam (Keppra®) and Placebo in the Treatment of Restless Legs Syndrome (RLS)

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Double Blind Crossover Trial of Levetiracetam (Keppra®) and Placebo in the Treatment of Restless Legs Syndrome (RLS)

Brief Summary: To define the effective dose and tolerability of levetiracetam in individuals with Restless Legs Syndrome (RLS). It is hypothesized that levetiracetam will be well tolerated, safe and effective in treating the symptoms of RLS.

Detailed Summary:
Sponsor: Sleep Health Centers

Current Primary Outcome:

• 1:To investigate the efficacy of levetiracetam when used to treat RLS.
• 2:To assess tolerability and adverse event rates.

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Sleep Health Centers

Dates:
Date Received: October 28, 2005
Date Started: November 2003
Date Completion: October 2005
Last Updated: October 28, 2005
Last Verified: October 2005